Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL273169

O=P(O)(O)OP(=O)(O)O.[LiH]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.91
BLM P54132 1/20 0.91
TDP1 Q9NUW8 1/20 0.91
ITPR3 Q14573 5/20 0.40
INPPL1 O15357 3/20 0.38
ITPR2 Q14571 1/20 0.38
ITPR1 Q14643 1/20 0.38
AKT1 P31749 1/20 0.38
CA4 P22748 1/20 0.37
CA2 P00918 1/20 0.36
INPP5A Q14642 2/20 0.35
SMPD1 P17405 1/20 0.35
INPP5B P32019 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL2217287 1.00 FDPS (0.91) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL27316005 1.00 FDPS (0.91) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL4455377 1.00 FDPS (0.91) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL19742227 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL20163217 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL23039087 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL11522910 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL7077187 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL21682893 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1
Pyrophosphoric Acid SCHEMBL11148168 0.96 FDPS (0.83) FDPSBLMTDP1ITPR3INPPL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 973 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132044-A1 SOLID-STATE ELECTROLYTE MATERIAL AND PREPARATION METHOD THEREOF, CATHODE ACTIVE MATERIAL, CATHODE PLATE, AND SOLID-STATE BATTERY BEIJING EASPRING MATERIAL TECH CO LTD (CN) 2026-05-14 US claimed
CN-122025539-A Negative electrode piece and lithium secondary battery comprising same 江苏睿恩新能源科技有限公司 2026-05-12 CN claimed
US-20260121034-A1 POSITIVE ELECTRODE ACTIVE MATERIAL AND PREPARATION METHOD AND USE THEREOF NINGBO RONBAY NEW ENERGY TECHNOLOGY Co.,Ltd. (CN) 2026-04-30 US claimed
EP-4723221-A1 POSITIVE ELECTRODE ACTIVE MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF Ningbo Ronbay New Energy Technology Co., Ltd. (CN) 2026-04-08 EP claimed
EP-4723247-A1 SOLID-STATE ELECTROLYTE MATERIAL AND PREPARATION METHOD THEREFOR, POSITIVE ELECTRODE ACTIVE MATERIAL, POSITIVE ELECTRODE SHEET, SOLID-STATE BATTERY AND ELECTRIC DEVICE Beijing Easpring Material Technology Co., Ltd. (CN) 2026-04-08 EP claimed
EP-4629336-A1 POSITIVE ELECTRODE ACTIVE MATERIAL FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY Panasonic Intellectual Property Management Co., Ltd. (JP) 2025-10-08 EP claimed
EP-4611098-A1 SOLID ELECTROLYTE AND ELECTRODE FOR A SOLID-STATE BATTERY COMPRISING FUNCTIONAL FILLERS AND DISPERSING AGENTS, AND METHODS FOR PRODUCING THE SAME SOLiTHOR (BE) 2025-09-03 EP claimed
CN-120202562-A Positive electrode active material for nonaqueous electrolyte secondary battery and nonaqueous electrolyte secondary battery 松下知识产权经营株式会社 2025-06-24 CN claimed
CN-119943914-A Lithium-rich manganese-based material with high ion channel and high stable surface, preparation method thereof and lithium ion battery 国联汽车动力电池研究院有限责任公司 2025-05-06 CN claimed
EP-4535999-A1 POLYETHERAMINE-BASED MULTIFUNCTIONAL BOOSTER COMPOSITIONS Troy Technology II, Inc. (US) 2025-04-16 EP claimed
EP-0906084-B1 TOOTHPASTE COMPOSITION COMPRISING A SILICA AND CALCIUM CARBONATE BASED ABRASIVE OR ADDITIVE, COMPATIBLE WITH FLUORINE RHODIA CHIMIE SA (FR) 2002-10-16 EP claimed
US-20020032261-A1 Resin composition for sliding member and sliding member using the same OILES CORPORATION (JP) 2002-03-14 US claimed
EP-1176165-A1 Resin composition for sliding member and sliding member using the same OILES CORPORATION (JP) 2002-01-30 EP claimed
EP-1132634-A2 Resin composition for sliding member, and sliding member produced therefrom OILES CORPORATION (JP) 2001-09-12 EP claimed
US-4957159-A ALKALI SILICATE COATING SHOWA ALUMINUM CORPORATION (JP) 1990-09-18 US claimed
US-4840731-A SERIES OF ISOLABLE REACTORS WITH REGENERABLE FIXED BED CATALYSTS; OXYGEN SOURCES SHEIKH MORRIS (US) 1989-06-20 US claimed
US-4741833-A CHEMICAL OXYGEN DEMAND SHEIKH MORRIS (US) 1988-05-03 US claimed
US-4683065-A OXYGEN DEMAND REDUCTION, TREATMENT WITH ALUMINA CATALYST SHEIKH MORRIS (US) 1987-07-28 US claimed
US-4500719-A Process for the preparation of N-alkenylphenylmaleimides and N,N'-[alkenylenephenylene]bismalemides MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1985-02-19 US claimed
US-4237105-A Thermochemical cyclic system for splitting water and/or carbon dioxide by means of cerium compounds and reactions useful therein THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1980-12-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132044-A1 SOLID-STATE ELECTROLYTE MATERIAL AND PREPARATION METHOD THEREOF, CATHODE ACTIVE MATERIAL, CATHODE PLATE, AND SOLID-STATE BATTERY NEK6, NEK11, NEK3 FDPS 4831/4885BLM 264/4885TDP1 2543/4885
US-20260121034-A1 POSITIVE ELECTRODE ACTIVE MATERIAL AND PREPARATION METHOD AND USE THEREOF ZYX, CACNA2D1, CACNA2D4 FDPS 4875/4885BLM 1416/4885TDP1 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.